Revelation Biosciences has its CRO for TITAN. Now Gemini faces the acute kidney injury test that really matters
Revelation Biosciences names Avance Clinical for the Phase 2/3 TITAN study as Gemini approaches its pivotal acute kidney injury test.
Pharma & Biotech